Healthcare Services Group, Inc. (HCSG) vs Maze Therapeutics, Inc. (MAZE)
A side-by-side comparison of Healthcare Services Group, Inc. and Maze Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCSG
Healthcare Services Group, Inc.
$21.08HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
MAZE
Maze Therapeutics, Inc.
$25.87HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — HCSG vs MAZE
growth of $100 · dividends reinvested · last 2yHCSG +87.7% (+37.0%/yr)MAZE +65.7% (+28.7%/yr)HCSG compounded faster over this window
HCSG MAZE
HCSG vs MAZE: by the numbers
- •HCSG is the larger company ($1.45B vs $1.43B market cap).
- •HCSG is profitable (6.59% net margin) while MAZE runs a net loss (-667.95%).
Metrics side by side
Valuation
| Metric | HCSG | MAZE |
|---|---|---|
| P/E ratio | 12.32 | N/A |
| Forward P/E | 17.57 | N/A |
| P/S ratio | 0.78 | 71.58 |
| P/B ratio | 2.79 | 3.16 |
| EV / EBITDA | 8.91 | N/A |
| FCF yield | 10.47% | N/A |
Profitability
| Metric | HCSG | MAZE |
|---|---|---|
| Gross margin | 17.33% | 0.00% |
| Operating margin | 7.03% | 0.00% |
| Net margin | 6.59% | -667.95% |
| ROE | 23.70% | -29.48% |
| ROIC | 16.83% | -28.63% |
Growth (annualized)
| Metric | HCSG | MAZE |
|---|---|---|
| Revenue CAGR (5Y) | 2.29% | N/A |
| EPS CAGR (5Y) | -9.08% | N/A |
| FCF CAGR (5Y) | -8.15% | N/A |
| Total return CAGR (5Y) | -2.00% | N/A |
Frequently asked
- Is HCSG or MAZE more profitable?
- HCSG runs the higher net margin — HCSG at 6.59% versus MAZE at -667.95%.
Go deeper
Dig into the metrics
Healthcare Services P/E ratioHealthcare Services ROEMaze Therapeutics ROEHealthcare Services operating marginMaze Therapeutics operating marginHealthcare Services revenue growthMaze Therapeutics revenue growthHealthcare Services free cash flowMaze Therapeutics free cash flow
Healthcare Services & Maze Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.